Results 121 to 130 of about 31,621 (232)

The epidemiology of inflammatory polyradiculoneuropathy, characteristics and outcome of the disease

, 1991
An outline of the principal reports dealing with the definition, distribution, course and treatment of the inflammatory polyradiculoneuropathies, including the Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP ...
Rizzuto N, SPECCHIO, LUIGI MARIA, Beghi E, Plasmapheresis study group, Tonali P, Cornelio F, Marconi M   +6 more
core  

Plasmapheresis in Chronic Active Antibody-Mediated Rejection

Turkish Journal of Nephrology, 2019
Plasmapheresis can be utilized as an adjunct to other methods to desensitize highly-sensitized potential renal transplant recipients or in the case of potential renal transplant recipients with ABO incompatible donors and for the treatment of acute ...
Güner KARAVELİ, Ebru GÖK OĞUZ, Tolga YILDIRIM, Zafer ERCAN, Özgür MERHAMETSİZ, Ayhan HASPULAT, Deniz AYLI   +6 more
doaj  

Iron and Other Metal Ions in Human Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
Iron, copper, zinc, and calcium orchestrate cellular function through distinct yet cooperative mechanisms: redox‐active iron and copper cycle between oxidation states to act as Fenton catalysts and electron carriers in oxidative phosphorylation (OXPHOS); redox‐inert zinc serves as a structural component of zinc‐finger proteins and a catalytic cofactor ...
Xiaofeng Dai, Jitian Li
wiley   +1 more source

Double filtration plasmapheresis in the treatment of cryoglobulinemic glomerulonephritis

, 1989
the paper discussed the effects of double filtration plasmapheresis in the treatment of cryoglobulinemic ...
Puccini R, Baronti R, Gremignai G, Casto G, FERRI, Clodoveo, Cecchetti R, Bombardieri S., Moriconi L, Cioni L   +8 more
core  

Benefit of modified plasmapheresis in the management of myasthenia gravis: a case report

, 2006
Background: Myasthenia gravis is an autoimmune disease condition caused by the generation of antibodies against the acetylcholine receptor sites at the neuromuscular junction.
Abjah, UMA, A Ogunniyi, Ocheni, S, S Ocheni, YA Akenova, OA Akinyemi, OA Talabi, Akinyemi, OA, Talabi, OA, Ogunniyi, A, UMA Abjah, Akenova, YA   +11 more
core   +1 more source

Remibrutinib as a Therapeutic Option for Solar Urticaria

Photodermatology, Photoimmunology &Photomedicine, Volume 42, Issue 6, November 2026.
Joshua Mijares, Manoj Bhagwat, Johanna Gonzalez, Vignesh Ramachandran   +3 more
wiley   +1 more source

Myasthenia Gravis and Thymoma

Muscle &Nerve, Volume 74, Issue 4, Page 1156-1173, October 2026.
ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Benjamin Claytor, Lukas Delasos, Daniel P. Raymond, Erik Seroogy, Jason Lempel, Yuebing Li   +5 more
wiley   +1 more source

Influence of patient factors on target plasma volume treated attainment rate during double filtration plasmapheresis in patients with hypertriglyceridemic acute pancreatitis

Therapeutic Apheresis and Dialysis, Volume 30, Issue 5, Page 690-697, October 2026.
Abstract Introduction This study aims to investigate patient factors affecting the rate of plasma volume target attained in hypertriglyceridemic pancreatitis (HTG‐AP) patients undergoing double filtration plasmapheresis (DFPP). Methods A retrospective analysis of 82 HTG‐AP‐interpreted patients from January 2019 to April 2024 compared target plasma ...
Hui Zhang, Chenqiang Zhu, Yunlong Wu
wiley   +1 more source

The Role of Plasmapheresis in the Management of Severe Rhesus Incompatibility During Pregnancy: A Literature Review

Reproductive, Female and Child Health
Introduction To evaluate the effectiveness and safety of plasmapheresis in cases complicated by severe alloimmunization. Methods We reviewed multiple studies from databases like Medline, Embase, and Cochrane, looking specifically for research on ‘Rhesus ...
Wael Abdallah, Assaad Kessrouani, Malek Nassar   +2 more
doaj   +1 more source

Belatacept Conversion in Simultaneous Pancreas‐Kidney and Liver‐Kidney Transplant Recipients: A Single‐Center Feasibility Cohort and Narrative Review

Clinical Transplantation, Volume 40, Issue 10, October 2026.
ABSTRACT Background Calcineurin inhibitor (CNI) nephrotoxicity drives long‐term kidney‐function decline after simultaneous pancreas‐kidney (SPK) and liver‐kidney (LK) transplantation, but belatacept conversion, as an alternative strategy, is poorly studied in these recipients, whose non‐kidney allograft rejection risk differs.
Dusan Harmacek, Elena Rho, Seraina von Moos, Severin Simmler, Thomas Welte, Fabian Rössler, Thomas Schachtner, Lukas Weidmann   +7 more
wiley   +1 more source